Symptom Indices and Quality-of-Life Questionnaires for Use in Benign Prostatic Hyperplasia
Summary The objective of this paper is to review available benign prostatic hyperplasia (BPH)-specific, symptoms-based and quality-of-life (QOL) questionnaires to provide researchers and clinicians with descriptive information on their content and psychometric properties (construct validity, interna...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Badía, Xavier [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
1997 |
|---|
| Schlagwörter: |
|---|
| Anmerkung: |
© Adis International Limited 1997 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Disease Management & Health Outcomes - Springer International Publishing, 1997, 2(1997), 6 vom: Dez., Seite 291-301 |
|---|---|
| Übergeordnetes Werk: |
volume:2 ; year:1997 ; number:6 ; month:12 ; pages:291-301 |
| Links: |
|---|
| DOI / URN: |
10.2165/00115677-199702060-00004 |
|---|
| Katalog-ID: |
SPR035650028 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR035650028 | ||
| 003 | DE-627 | ||
| 005 | 20230519112255.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201007s1997 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2165/00115677-199702060-00004 |2 doi | |
| 035 | |a (DE-627)SPR035650028 | ||
| 035 | |a (SPR)00115677-199702060-00004-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Badía, Xavier |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Symptom Indices and Quality-of-Life Questionnaires for Use in Benign Prostatic Hyperplasia |
| 264 | 1 | |c 1997 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © Adis International Limited 1997 | ||
| 520 | |a Summary The objective of this paper is to review available benign prostatic hyperplasia (BPH)-specific, symptoms-based and quality-of-life (QOL) questionnaires to provide researchers and clinicians with descriptive information on their content and psychometric properties (construct validity, internal consistency, test-retest reliability and sensitivity to change). This will provide a basis for selecting instruments for use in research and clinical practice. 11 questionnaires were found in a literature search [Boyarsky Scoring System, Madsen-Iversen Scoring System, Maine Medical Assessment Program (MMAP) Symptom Index, Epstein’s Benign Prostatic Hyperplasia Health-Related Quality of Life Questionnaire, American Urological Association/International Prostate Symptom Score (AUA-7/I-PSS) BPH Symptom Index, Eri’s Visual Analogue Scale, the Danish Prostatic Symptom Score, the French BPH-specific Quality-of-Life Scale, Barry’s Symptom Problem Index (SPI), Barry’s BPH Impact Index (BII), and the International Continence Society Male (ICSm) Questionnaire]. Frequency, intermittency, urgency, stream, strain and nocturia were the symptoms most frequently included in these instruments. Validity, reliability and sensitivity to change had been assessed for the majority of instruments but the extent and thoroughness of this testing varied greatly. There are numerous validated instruments for use with BPH patients. The choice of instrument should be based on the requirements of particular studies, or on clinical grounds. | ||
| 650 | 4 | |a Adis International Limited |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Benign Prostatic Hyperplasia |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a International Prostate Symptom Score |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Symptom Index |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Benign Prostatic Hyperplasia Patient |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a García-Losa, Manuel |4 aut | |
| 700 | 1 | |a Serra, Mateu |4 aut | |
| 700 | 1 | |a Carballido, Joaquín |4 aut | |
| 700 | 1 | |a Herdman, Michael |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Disease Management & Health Outcomes |d Springer International Publishing, 1997 |g 2(1997), 6 vom: Dez., Seite 291-301 |w (DE-627)SPR035648813 |7 nnns |
| 773 | 1 | 8 | |g volume:2 |g year:1997 |g number:6 |g month:12 |g pages:291-301 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.2165/00115677-199702060-00004 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 2 |j 1997 |e 6 |c 12 |h 291-301 | ||
| author_variant |
x b xb m g l mgl m s ms j c jc m h mh |
|---|---|
| matchkey_str |
badaxaviergarcalosamanuelserramateucarba:1997----:ypoidcsnqaiyfieusinarsouenei |
| hierarchy_sort_str |
1997 |
| publishDate |
1997 |
| allfields |
10.2165/00115677-199702060-00004 doi (DE-627)SPR035650028 (SPR)00115677-199702060-00004-e DE-627 ger DE-627 rakwb eng Badía, Xavier verfasserin aut Symptom Indices and Quality-of-Life Questionnaires for Use in Benign Prostatic Hyperplasia 1997 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Limited 1997 Summary The objective of this paper is to review available benign prostatic hyperplasia (BPH)-specific, symptoms-based and quality-of-life (QOL) questionnaires to provide researchers and clinicians with descriptive information on their content and psychometric properties (construct validity, internal consistency, test-retest reliability and sensitivity to change). This will provide a basis for selecting instruments for use in research and clinical practice. 11 questionnaires were found in a literature search [Boyarsky Scoring System, Madsen-Iversen Scoring System, Maine Medical Assessment Program (MMAP) Symptom Index, Epstein’s Benign Prostatic Hyperplasia Health-Related Quality of Life Questionnaire, American Urological Association/International Prostate Symptom Score (AUA-7/I-PSS) BPH Symptom Index, Eri’s Visual Analogue Scale, the Danish Prostatic Symptom Score, the French BPH-specific Quality-of-Life Scale, Barry’s Symptom Problem Index (SPI), Barry’s BPH Impact Index (BII), and the International Continence Society Male (ICSm) Questionnaire]. Frequency, intermittency, urgency, stream, strain and nocturia were the symptoms most frequently included in these instruments. Validity, reliability and sensitivity to change had been assessed for the majority of instruments but the extent and thoroughness of this testing varied greatly. There are numerous validated instruments for use with BPH patients. The choice of instrument should be based on the requirements of particular studies, or on clinical grounds. Adis International Limited (dpeaa)DE-He213 Benign Prostatic Hyperplasia (dpeaa)DE-He213 International Prostate Symptom Score (dpeaa)DE-He213 Symptom Index (dpeaa)DE-He213 Benign Prostatic Hyperplasia Patient (dpeaa)DE-He213 García-Losa, Manuel aut Serra, Mateu aut Carballido, Joaquín aut Herdman, Michael aut Enthalten in Disease Management & Health Outcomes Springer International Publishing, 1997 2(1997), 6 vom: Dez., Seite 291-301 (DE-627)SPR035648813 nnns volume:2 year:1997 number:6 month:12 pages:291-301 https://dx.doi.org/10.2165/00115677-199702060-00004 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA AR 2 1997 6 12 291-301 |
| spelling |
10.2165/00115677-199702060-00004 doi (DE-627)SPR035650028 (SPR)00115677-199702060-00004-e DE-627 ger DE-627 rakwb eng Badía, Xavier verfasserin aut Symptom Indices and Quality-of-Life Questionnaires for Use in Benign Prostatic Hyperplasia 1997 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Limited 1997 Summary The objective of this paper is to review available benign prostatic hyperplasia (BPH)-specific, symptoms-based and quality-of-life (QOL) questionnaires to provide researchers and clinicians with descriptive information on their content and psychometric properties (construct validity, internal consistency, test-retest reliability and sensitivity to change). This will provide a basis for selecting instruments for use in research and clinical practice. 11 questionnaires were found in a literature search [Boyarsky Scoring System, Madsen-Iversen Scoring System, Maine Medical Assessment Program (MMAP) Symptom Index, Epstein’s Benign Prostatic Hyperplasia Health-Related Quality of Life Questionnaire, American Urological Association/International Prostate Symptom Score (AUA-7/I-PSS) BPH Symptom Index, Eri’s Visual Analogue Scale, the Danish Prostatic Symptom Score, the French BPH-specific Quality-of-Life Scale, Barry’s Symptom Problem Index (SPI), Barry’s BPH Impact Index (BII), and the International Continence Society Male (ICSm) Questionnaire]. Frequency, intermittency, urgency, stream, strain and nocturia were the symptoms most frequently included in these instruments. Validity, reliability and sensitivity to change had been assessed for the majority of instruments but the extent and thoroughness of this testing varied greatly. There are numerous validated instruments for use with BPH patients. The choice of instrument should be based on the requirements of particular studies, or on clinical grounds. Adis International Limited (dpeaa)DE-He213 Benign Prostatic Hyperplasia (dpeaa)DE-He213 International Prostate Symptom Score (dpeaa)DE-He213 Symptom Index (dpeaa)DE-He213 Benign Prostatic Hyperplasia Patient (dpeaa)DE-He213 García-Losa, Manuel aut Serra, Mateu aut Carballido, Joaquín aut Herdman, Michael aut Enthalten in Disease Management & Health Outcomes Springer International Publishing, 1997 2(1997), 6 vom: Dez., Seite 291-301 (DE-627)SPR035648813 nnns volume:2 year:1997 number:6 month:12 pages:291-301 https://dx.doi.org/10.2165/00115677-199702060-00004 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA AR 2 1997 6 12 291-301 |
| allfields_unstemmed |
10.2165/00115677-199702060-00004 doi (DE-627)SPR035650028 (SPR)00115677-199702060-00004-e DE-627 ger DE-627 rakwb eng Badía, Xavier verfasserin aut Symptom Indices and Quality-of-Life Questionnaires for Use in Benign Prostatic Hyperplasia 1997 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Limited 1997 Summary The objective of this paper is to review available benign prostatic hyperplasia (BPH)-specific, symptoms-based and quality-of-life (QOL) questionnaires to provide researchers and clinicians with descriptive information on their content and psychometric properties (construct validity, internal consistency, test-retest reliability and sensitivity to change). This will provide a basis for selecting instruments for use in research and clinical practice. 11 questionnaires were found in a literature search [Boyarsky Scoring System, Madsen-Iversen Scoring System, Maine Medical Assessment Program (MMAP) Symptom Index, Epstein’s Benign Prostatic Hyperplasia Health-Related Quality of Life Questionnaire, American Urological Association/International Prostate Symptom Score (AUA-7/I-PSS) BPH Symptom Index, Eri’s Visual Analogue Scale, the Danish Prostatic Symptom Score, the French BPH-specific Quality-of-Life Scale, Barry’s Symptom Problem Index (SPI), Barry’s BPH Impact Index (BII), and the International Continence Society Male (ICSm) Questionnaire]. Frequency, intermittency, urgency, stream, strain and nocturia were the symptoms most frequently included in these instruments. Validity, reliability and sensitivity to change had been assessed for the majority of instruments but the extent and thoroughness of this testing varied greatly. There are numerous validated instruments for use with BPH patients. The choice of instrument should be based on the requirements of particular studies, or on clinical grounds. Adis International Limited (dpeaa)DE-He213 Benign Prostatic Hyperplasia (dpeaa)DE-He213 International Prostate Symptom Score (dpeaa)DE-He213 Symptom Index (dpeaa)DE-He213 Benign Prostatic Hyperplasia Patient (dpeaa)DE-He213 García-Losa, Manuel aut Serra, Mateu aut Carballido, Joaquín aut Herdman, Michael aut Enthalten in Disease Management & Health Outcomes Springer International Publishing, 1997 2(1997), 6 vom: Dez., Seite 291-301 (DE-627)SPR035648813 nnns volume:2 year:1997 number:6 month:12 pages:291-301 https://dx.doi.org/10.2165/00115677-199702060-00004 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA AR 2 1997 6 12 291-301 |
| allfieldsGer |
10.2165/00115677-199702060-00004 doi (DE-627)SPR035650028 (SPR)00115677-199702060-00004-e DE-627 ger DE-627 rakwb eng Badía, Xavier verfasserin aut Symptom Indices and Quality-of-Life Questionnaires for Use in Benign Prostatic Hyperplasia 1997 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Limited 1997 Summary The objective of this paper is to review available benign prostatic hyperplasia (BPH)-specific, symptoms-based and quality-of-life (QOL) questionnaires to provide researchers and clinicians with descriptive information on their content and psychometric properties (construct validity, internal consistency, test-retest reliability and sensitivity to change). This will provide a basis for selecting instruments for use in research and clinical practice. 11 questionnaires were found in a literature search [Boyarsky Scoring System, Madsen-Iversen Scoring System, Maine Medical Assessment Program (MMAP) Symptom Index, Epstein’s Benign Prostatic Hyperplasia Health-Related Quality of Life Questionnaire, American Urological Association/International Prostate Symptom Score (AUA-7/I-PSS) BPH Symptom Index, Eri’s Visual Analogue Scale, the Danish Prostatic Symptom Score, the French BPH-specific Quality-of-Life Scale, Barry’s Symptom Problem Index (SPI), Barry’s BPH Impact Index (BII), and the International Continence Society Male (ICSm) Questionnaire]. Frequency, intermittency, urgency, stream, strain and nocturia were the symptoms most frequently included in these instruments. Validity, reliability and sensitivity to change had been assessed for the majority of instruments but the extent and thoroughness of this testing varied greatly. There are numerous validated instruments for use with BPH patients. The choice of instrument should be based on the requirements of particular studies, or on clinical grounds. Adis International Limited (dpeaa)DE-He213 Benign Prostatic Hyperplasia (dpeaa)DE-He213 International Prostate Symptom Score (dpeaa)DE-He213 Symptom Index (dpeaa)DE-He213 Benign Prostatic Hyperplasia Patient (dpeaa)DE-He213 García-Losa, Manuel aut Serra, Mateu aut Carballido, Joaquín aut Herdman, Michael aut Enthalten in Disease Management & Health Outcomes Springer International Publishing, 1997 2(1997), 6 vom: Dez., Seite 291-301 (DE-627)SPR035648813 nnns volume:2 year:1997 number:6 month:12 pages:291-301 https://dx.doi.org/10.2165/00115677-199702060-00004 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA AR 2 1997 6 12 291-301 |
| allfieldsSound |
10.2165/00115677-199702060-00004 doi (DE-627)SPR035650028 (SPR)00115677-199702060-00004-e DE-627 ger DE-627 rakwb eng Badía, Xavier verfasserin aut Symptom Indices and Quality-of-Life Questionnaires for Use in Benign Prostatic Hyperplasia 1997 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Limited 1997 Summary The objective of this paper is to review available benign prostatic hyperplasia (BPH)-specific, symptoms-based and quality-of-life (QOL) questionnaires to provide researchers and clinicians with descriptive information on their content and psychometric properties (construct validity, internal consistency, test-retest reliability and sensitivity to change). This will provide a basis for selecting instruments for use in research and clinical practice. 11 questionnaires were found in a literature search [Boyarsky Scoring System, Madsen-Iversen Scoring System, Maine Medical Assessment Program (MMAP) Symptom Index, Epstein’s Benign Prostatic Hyperplasia Health-Related Quality of Life Questionnaire, American Urological Association/International Prostate Symptom Score (AUA-7/I-PSS) BPH Symptom Index, Eri’s Visual Analogue Scale, the Danish Prostatic Symptom Score, the French BPH-specific Quality-of-Life Scale, Barry’s Symptom Problem Index (SPI), Barry’s BPH Impact Index (BII), and the International Continence Society Male (ICSm) Questionnaire]. Frequency, intermittency, urgency, stream, strain and nocturia were the symptoms most frequently included in these instruments. Validity, reliability and sensitivity to change had been assessed for the majority of instruments but the extent and thoroughness of this testing varied greatly. There are numerous validated instruments for use with BPH patients. The choice of instrument should be based on the requirements of particular studies, or on clinical grounds. Adis International Limited (dpeaa)DE-He213 Benign Prostatic Hyperplasia (dpeaa)DE-He213 International Prostate Symptom Score (dpeaa)DE-He213 Symptom Index (dpeaa)DE-He213 Benign Prostatic Hyperplasia Patient (dpeaa)DE-He213 García-Losa, Manuel aut Serra, Mateu aut Carballido, Joaquín aut Herdman, Michael aut Enthalten in Disease Management & Health Outcomes Springer International Publishing, 1997 2(1997), 6 vom: Dez., Seite 291-301 (DE-627)SPR035648813 nnns volume:2 year:1997 number:6 month:12 pages:291-301 https://dx.doi.org/10.2165/00115677-199702060-00004 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA AR 2 1997 6 12 291-301 |
| language |
English |
| source |
Enthalten in Disease Management & Health Outcomes 2(1997), 6 vom: Dez., Seite 291-301 volume:2 year:1997 number:6 month:12 pages:291-301 |
| sourceStr |
Enthalten in Disease Management & Health Outcomes 2(1997), 6 vom: Dez., Seite 291-301 volume:2 year:1997 number:6 month:12 pages:291-301 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Adis International Limited Benign Prostatic Hyperplasia International Prostate Symptom Score Symptom Index Benign Prostatic Hyperplasia Patient |
| isfreeaccess_bool |
false |
| container_title |
Disease Management & Health Outcomes |
| authorswithroles_txt_mv |
Badía, Xavier @@aut@@ García-Losa, Manuel @@aut@@ Serra, Mateu @@aut@@ Carballido, Joaquín @@aut@@ Herdman, Michael @@aut@@ |
| publishDateDaySort_date |
1997-12-01T00:00:00Z |
| hierarchy_top_id |
SPR035648813 |
| id |
SPR035650028 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035650028</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519112255.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s1997 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00115677-199702060-00004</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035650028</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00115677-199702060-00004-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Badía, Xavier</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Symptom Indices and Quality-of-Life Questionnaires for Use in Benign Prostatic Hyperplasia</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1997</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Limited 1997</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Summary The objective of this paper is to review available benign prostatic hyperplasia (BPH)-specific, symptoms-based and quality-of-life (QOL) questionnaires to provide researchers and clinicians with descriptive information on their content and psychometric properties (construct validity, internal consistency, test-retest reliability and sensitivity to change). This will provide a basis for selecting instruments for use in research and clinical practice. 11 questionnaires were found in a literature search [Boyarsky Scoring System, Madsen-Iversen Scoring System, Maine Medical Assessment Program (MMAP) Symptom Index, Epstein’s Benign Prostatic Hyperplasia Health-Related Quality of Life Questionnaire, American Urological Association/International Prostate Symptom Score (AUA-7/I-PSS) BPH Symptom Index, Eri’s Visual Analogue Scale, the Danish Prostatic Symptom Score, the French BPH-specific Quality-of-Life Scale, Barry’s Symptom Problem Index (SPI), Barry’s BPH Impact Index (BII), and the International Continence Society Male (ICSm) Questionnaire]. Frequency, intermittency, urgency, stream, strain and nocturia were the symptoms most frequently included in these instruments. Validity, reliability and sensitivity to change had been assessed for the majority of instruments but the extent and thoroughness of this testing varied greatly. There are numerous validated instruments for use with BPH patients. The choice of instrument should be based on the requirements of particular studies, or on clinical grounds.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Adis International Limited</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Benign Prostatic Hyperplasia</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">International Prostate Symptom Score</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Symptom Index</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Benign Prostatic Hyperplasia Patient</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">García-Losa, Manuel</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Serra, Mateu</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Carballido, Joaquín</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Herdman, Michael</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Disease Management & Health Outcomes</subfield><subfield code="d">Springer International Publishing, 1997</subfield><subfield code="g">2(1997), 6 vom: Dez., Seite 291-301</subfield><subfield code="w">(DE-627)SPR035648813</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:2</subfield><subfield code="g">year:1997</subfield><subfield code="g">number:6</subfield><subfield code="g">month:12</subfield><subfield code="g">pages:291-301</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00115677-199702060-00004</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">2</subfield><subfield code="j">1997</subfield><subfield code="e">6</subfield><subfield code="c">12</subfield><subfield code="h">291-301</subfield></datafield></record></collection>
|
| author |
Badía, Xavier |
| spellingShingle |
Badía, Xavier misc Adis International Limited misc Benign Prostatic Hyperplasia misc International Prostate Symptom Score misc Symptom Index misc Benign Prostatic Hyperplasia Patient Symptom Indices and Quality-of-Life Questionnaires for Use in Benign Prostatic Hyperplasia |
| authorStr |
Badía, Xavier |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)SPR035648813 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut aut aut aut |
| collection |
springer |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
Symptom Indices and Quality-of-Life Questionnaires for Use in Benign Prostatic Hyperplasia Adis International Limited (dpeaa)DE-He213 Benign Prostatic Hyperplasia (dpeaa)DE-He213 International Prostate Symptom Score (dpeaa)DE-He213 Symptom Index (dpeaa)DE-He213 Benign Prostatic Hyperplasia Patient (dpeaa)DE-He213 |
| topic |
misc Adis International Limited misc Benign Prostatic Hyperplasia misc International Prostate Symptom Score misc Symptom Index misc Benign Prostatic Hyperplasia Patient |
| topic_unstemmed |
misc Adis International Limited misc Benign Prostatic Hyperplasia misc International Prostate Symptom Score misc Symptom Index misc Benign Prostatic Hyperplasia Patient |
| topic_browse |
misc Adis International Limited misc Benign Prostatic Hyperplasia misc International Prostate Symptom Score misc Symptom Index misc Benign Prostatic Hyperplasia Patient |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
Disease Management & Health Outcomes |
| hierarchy_parent_id |
SPR035648813 |
| hierarchy_top_title |
Disease Management & Health Outcomes |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)SPR035648813 |
| title |
Symptom Indices and Quality-of-Life Questionnaires for Use in Benign Prostatic Hyperplasia |
| ctrlnum |
(DE-627)SPR035650028 (SPR)00115677-199702060-00004-e |
| title_full |
Symptom Indices and Quality-of-Life Questionnaires for Use in Benign Prostatic Hyperplasia |
| author_sort |
Badía, Xavier |
| journal |
Disease Management & Health Outcomes |
| journalStr |
Disease Management & Health Outcomes |
| lang_code |
eng |
| isOA_bool |
false |
| recordtype |
marc |
| publishDateSort |
1997 |
| contenttype_str_mv |
txt |
| container_start_page |
291 |
| author_browse |
Badía, Xavier García-Losa, Manuel Serra, Mateu Carballido, Joaquín Herdman, Michael |
| container_volume |
2 |
| format_se |
Elektronische Aufsätze |
| author-letter |
Badía, Xavier |
| doi_str_mv |
10.2165/00115677-199702060-00004 |
| title_sort |
symptom indices and quality-of-life questionnaires for use in benign prostatic hyperplasia |
| title_auth |
Symptom Indices and Quality-of-Life Questionnaires for Use in Benign Prostatic Hyperplasia |
| abstract |
Summary The objective of this paper is to review available benign prostatic hyperplasia (BPH)-specific, symptoms-based and quality-of-life (QOL) questionnaires to provide researchers and clinicians with descriptive information on their content and psychometric properties (construct validity, internal consistency, test-retest reliability and sensitivity to change). This will provide a basis for selecting instruments for use in research and clinical practice. 11 questionnaires were found in a literature search [Boyarsky Scoring System, Madsen-Iversen Scoring System, Maine Medical Assessment Program (MMAP) Symptom Index, Epstein’s Benign Prostatic Hyperplasia Health-Related Quality of Life Questionnaire, American Urological Association/International Prostate Symptom Score (AUA-7/I-PSS) BPH Symptom Index, Eri’s Visual Analogue Scale, the Danish Prostatic Symptom Score, the French BPH-specific Quality-of-Life Scale, Barry’s Symptom Problem Index (SPI), Barry’s BPH Impact Index (BII), and the International Continence Society Male (ICSm) Questionnaire]. Frequency, intermittency, urgency, stream, strain and nocturia were the symptoms most frequently included in these instruments. Validity, reliability and sensitivity to change had been assessed for the majority of instruments but the extent and thoroughness of this testing varied greatly. There are numerous validated instruments for use with BPH patients. The choice of instrument should be based on the requirements of particular studies, or on clinical grounds. © Adis International Limited 1997 |
| abstractGer |
Summary The objective of this paper is to review available benign prostatic hyperplasia (BPH)-specific, symptoms-based and quality-of-life (QOL) questionnaires to provide researchers and clinicians with descriptive information on their content and psychometric properties (construct validity, internal consistency, test-retest reliability and sensitivity to change). This will provide a basis for selecting instruments for use in research and clinical practice. 11 questionnaires were found in a literature search [Boyarsky Scoring System, Madsen-Iversen Scoring System, Maine Medical Assessment Program (MMAP) Symptom Index, Epstein’s Benign Prostatic Hyperplasia Health-Related Quality of Life Questionnaire, American Urological Association/International Prostate Symptom Score (AUA-7/I-PSS) BPH Symptom Index, Eri’s Visual Analogue Scale, the Danish Prostatic Symptom Score, the French BPH-specific Quality-of-Life Scale, Barry’s Symptom Problem Index (SPI), Barry’s BPH Impact Index (BII), and the International Continence Society Male (ICSm) Questionnaire]. Frequency, intermittency, urgency, stream, strain and nocturia were the symptoms most frequently included in these instruments. Validity, reliability and sensitivity to change had been assessed for the majority of instruments but the extent and thoroughness of this testing varied greatly. There are numerous validated instruments for use with BPH patients. The choice of instrument should be based on the requirements of particular studies, or on clinical grounds. © Adis International Limited 1997 |
| abstract_unstemmed |
Summary The objective of this paper is to review available benign prostatic hyperplasia (BPH)-specific, symptoms-based and quality-of-life (QOL) questionnaires to provide researchers and clinicians with descriptive information on their content and psychometric properties (construct validity, internal consistency, test-retest reliability and sensitivity to change). This will provide a basis for selecting instruments for use in research and clinical practice. 11 questionnaires were found in a literature search [Boyarsky Scoring System, Madsen-Iversen Scoring System, Maine Medical Assessment Program (MMAP) Symptom Index, Epstein’s Benign Prostatic Hyperplasia Health-Related Quality of Life Questionnaire, American Urological Association/International Prostate Symptom Score (AUA-7/I-PSS) BPH Symptom Index, Eri’s Visual Analogue Scale, the Danish Prostatic Symptom Score, the French BPH-specific Quality-of-Life Scale, Barry’s Symptom Problem Index (SPI), Barry’s BPH Impact Index (BII), and the International Continence Society Male (ICSm) Questionnaire]. Frequency, intermittency, urgency, stream, strain and nocturia were the symptoms most frequently included in these instruments. Validity, reliability and sensitivity to change had been assessed for the majority of instruments but the extent and thoroughness of this testing varied greatly. There are numerous validated instruments for use with BPH patients. The choice of instrument should be based on the requirements of particular studies, or on clinical grounds. © Adis International Limited 1997 |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA |
| container_issue |
6 |
| title_short |
Symptom Indices and Quality-of-Life Questionnaires for Use in Benign Prostatic Hyperplasia |
| url |
https://dx.doi.org/10.2165/00115677-199702060-00004 |
| remote_bool |
true |
| author2 |
García-Losa, Manuel Serra, Mateu Carballido, Joaquín Herdman, Michael |
| author2Str |
García-Losa, Manuel Serra, Mateu Carballido, Joaquín Herdman, Michael |
| ppnlink |
SPR035648813 |
| mediatype_str_mv |
c |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| doi_str |
10.2165/00115677-199702060-00004 |
| up_date |
2024-07-03T15:30:52.673Z |
| _version_ |
1803572375894097920 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035650028</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519112255.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s1997 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00115677-199702060-00004</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035650028</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00115677-199702060-00004-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Badía, Xavier</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Symptom Indices and Quality-of-Life Questionnaires for Use in Benign Prostatic Hyperplasia</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1997</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Limited 1997</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Summary The objective of this paper is to review available benign prostatic hyperplasia (BPH)-specific, symptoms-based and quality-of-life (QOL) questionnaires to provide researchers and clinicians with descriptive information on their content and psychometric properties (construct validity, internal consistency, test-retest reliability and sensitivity to change). This will provide a basis for selecting instruments for use in research and clinical practice. 11 questionnaires were found in a literature search [Boyarsky Scoring System, Madsen-Iversen Scoring System, Maine Medical Assessment Program (MMAP) Symptom Index, Epstein’s Benign Prostatic Hyperplasia Health-Related Quality of Life Questionnaire, American Urological Association/International Prostate Symptom Score (AUA-7/I-PSS) BPH Symptom Index, Eri’s Visual Analogue Scale, the Danish Prostatic Symptom Score, the French BPH-specific Quality-of-Life Scale, Barry’s Symptom Problem Index (SPI), Barry’s BPH Impact Index (BII), and the International Continence Society Male (ICSm) Questionnaire]. Frequency, intermittency, urgency, stream, strain and nocturia were the symptoms most frequently included in these instruments. Validity, reliability and sensitivity to change had been assessed for the majority of instruments but the extent and thoroughness of this testing varied greatly. There are numerous validated instruments for use with BPH patients. The choice of instrument should be based on the requirements of particular studies, or on clinical grounds.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Adis International Limited</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Benign Prostatic Hyperplasia</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">International Prostate Symptom Score</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Symptom Index</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Benign Prostatic Hyperplasia Patient</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">García-Losa, Manuel</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Serra, Mateu</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Carballido, Joaquín</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Herdman, Michael</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Disease Management & Health Outcomes</subfield><subfield code="d">Springer International Publishing, 1997</subfield><subfield code="g">2(1997), 6 vom: Dez., Seite 291-301</subfield><subfield code="w">(DE-627)SPR035648813</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:2</subfield><subfield code="g">year:1997</subfield><subfield code="g">number:6</subfield><subfield code="g">month:12</subfield><subfield code="g">pages:291-301</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00115677-199702060-00004</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">2</subfield><subfield code="j">1997</subfield><subfield code="e">6</subfield><subfield code="c">12</subfield><subfield code="h">291-301</subfield></datafield></record></collection>
|
| score |
7.4012003 |